Drug recall
Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa…
FDA recall event 88090 · Class II · CIPLA
Key facts
| Event ID | 88090 |
|---|---|
| Recall numbers | D-0660-2021 |
| Recalling firm | CIPLA |
| Product type | Drugs |
| Products | Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India Manufactured for Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | CGMP Deviations |
| Initiation date | Jun 10, 2021 |
| Report date | Jul 21, 2021 |
| Termination date | Jan 10, 2024 |
| City | Warren |
| State | NJ |
| Country | United States |
| FEI number | 3014780658 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: